close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

47.42 -1.03 (-2.13%)
Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novo Nordisk A/S Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
News headline image
Skye Bioscience's Investigational Drug Disappoints As Monotherapy For Weight Loss ↗
Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger weight loss results. 
Via Benzinga
News headline image
2 Beaten-Down Stocks Primed for a Comeback ↗
The market is sleeping on these stocks, but you don't have to. 
Via The Motley Fool
News headline image
Anthropic’s Claude AI: Seamless Integration into Everyday Life
Anthropic, a leading artificial intelligence research company, is making significant strides in embedding its powerful Claude AI into the fabric of daily applications and enterprise workflows. With a... 
Via TokenRing AI
Topics Artificial Intelligence
Novo Nordisk Retail Traders Stay Bullish Despite Brutal 2025 — Analysts Flag A Key Catalyst That Can Turn Things Around ↗
Via Stocktwits
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients ↗
Via Stocktwits
Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today ↗
Via Stocktwits
Chinese Biotech Takes Aim At Eli Lilly, Novo Nordisk With New GLP-1 Weight-Loss Drugs As Patent Clocks Tick ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength
Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC.... 
Via MarketMinute
Topics Economy
News headline image
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
Novo Nordisk (NYSE:NVO) Presents a Compelling Case for Value Investors ↗
Novo Nordisk (NVO) presents a strong value investment case with an attractive valuation, high profitability, and solid financial health. 
Via Chartmill
News headline image
Why Shares in Novo Nordisk Bumped Higher Today ↗
Pfizer's deal with the Trump administration raised hopes that the European company wouldn't be subject to 100% tariffs on certain imported drugs. 
Via The Motley Fool
Topics Government World Trade
News headline image
Q3 2025 Market Marvels: S&P 500's Standout Performers and Their Catalysts
As the third quarter of 2025 draws to a close, the financial markets are abuzz with the exceptional performances of several S&P 500 companies. While official data is still being compiled, preliminary... 
Via MarketMinute
Topics Artificial Intelligence Data Breach Earnings
News headline image
Pfizer Plummets as Key Obesity Drug Candidate Faces Major Setback, Shaking Investor Confidence
New York, NY – September 30, 2025 – Shares of pharmaceutical giant Pfizer (NYSE: PFE) experienced a dramatic decline today, making it one of the market's bottom performers, following an unexpected and... 
Via MarketMinute
Topics Intellectual Property
News headline image
Trump's Plan To Lower U.S. Drug Prices Faces Big Test ↗
But Trump might get less than he bargained for as drugmakers focus on prices abroad, rather than stateside efforts. 
Via Investor's Business Daily
Topics Government
News headline image
Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity? ↗
Political pressure on Big Pharma is one reason why the industry is underperforming in 2025. 
Via The Motley Fool
News headline image
These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead ↗
It's hard to keep these longtime winners down for too long. 
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
News headline image
Why Novo Nordisk Stock Slumped on Monday ↗
A pundit tracking the company cited several reasons why investors should sell out of it. 
Via The Motley Fool
Topics World Trade
News headline image
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1... 
Via Benzinga
Topics Stocks
News headline image
3 Magnificent Stocks Under $100 to Buy Right Now ↗
You won't need a huge amount of cash to invest in these great pharma stocks. 
Via The Motley Fool
News headline image
Consumers Splurge, Intel, GlobalFoundries, Lilly, Paccar, American Woodmark Benefit From New Tariffs ↗
To gain an edge, this is what you need to know today. 
Via Benzinga
News headline image
Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility
September 26, 2025 – Global financial markets are once again in the throes of uncertainty as the United States unveils a fresh wave of substantial trade tariffs, set to take effect on October 1, 2025.... 
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗
Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de 
Via Benzinga
Topics Government World Trade
News headline image
Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. ↗
Recent data from a head-to-head trial was positive for Eli Lilly, but it's not the whole story. 
Via The Motley Fool
News headline image
3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now ↗
These stocks come with some uncertainty, but they have strong fundamentals and trade at low earnings multiples. 
Via The Motley Fool
Topics World Trade
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America ↗
Via Stocktwits
Topics Government
News headline image
Does This Acquisition Make Pfizer Stock a Great Buy? ↗
There's an opportunity to get in on the weight-loss drug craze at a reasonable price. 
Via The Motley Fool
Topics Death Intellectual Property
News headline image
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today ↗
The latest data from the company's oral weight loss drug is bullish for the stock. 
Via The Motley Fool
Topics Economy
News headline image
3 Reasons to Buy Novo Nordisk Stock Right Now ↗
The pharmaceutical leader is gradually laying the groundwork for a strong rebound. 
Via The Motley Fool
News headline image
Direxion's Ultra-Leveraged CURE ETF Offers An Opportunity To Play The Potential Valuation Reset ↗
 
Via Benzinga
Topics ETFs
News headline image
Scholar Rock, A Top 10% Stock, Dives After Catalent Issues Hamper SMA Drug ↗
Shares tumbled Tuesday after the FDA rejected the company's spinal muscular atrophy drug. 
Via Investor's Business Daily
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today